IP Verse

Botti & Ferrari patent opposition analysis

The comprehensive analysis of Botti & Ferrari opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Botti & Ferrari

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP4069254	Combination Decitabine And Cedazuridine Solid Oral Dosage Forms	OTSUKA PHARMACEUTICAL	Jun 11, 2025	BOTTI & FERRARI
EP3595667	Pharmaceutical Compositions Comprising A Jak Inhibitor	GALAPAGOS	Sep 17, 2024	BOTTI & FERRARI
EP3526170	Method For Producing Mineral Fibres	SAINT GOBAIN	Sep 6, 2024	STM
EP2497650	Method For Processing A Structured Surface Of An Embossing Tool	HUECK RHEINISCHE	Jul 11, 2024	SESA
EP3500241	Combination Therapy For Copd	CHIESI FARMACEUTICI	Jul 3, 2024	BOTTI & FERRARI
EP3634463	Improved Protocol For Treatment Of Lupus Nephritis	AURINIA PHARMACEUTICALS	Jun 26, 2024	BOTTI & FERRARI
EP3307271	Methods Of Using Pyruvate Kinase Activators	AGIOS PHARMACEUTICALS	Jun 11, 2024	BOTTI & FERRARI
EP3713919	Crystalline Forms Of N-(4-(4-(Cyclopropylmethyl) Piperazine-1-Carbonyl)Phenyl)Quinoline-8-Sulfonamide	AGIOS PHARMACEUTICALS	May 2, 2024	BOTTI & FERRARI
EP3844256	Mash Filter Membrane	HEINEKEN SUPPLY CHAIN	Mar 7, 2024	BOTTI & FERRARI
EP2826903	Mineral Fiber Insulation Product	KNAUF INSULATION	Jan 25, 2024	STM

Top companies who are the clients of Botti & Ferrari